145 related articles for article (PubMed ID: 9836756)
61. Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy.
Durany N; Ravid R; Riederer P; Cruz-Sánchez FF
Neuropathology; 2000 Sep; 20(3):184-9. PubMed ID: 11132933
[TBL] [Abstract][Full Text] [Related]
62. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
63. Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
Nagaraja N; Wang WE; Duara R; DeKosky ST; Vaillancourt D
J Alzheimers Dis; 2023; 93(2):495-507. PubMed ID: 37038809
[TBL] [Abstract][Full Text] [Related]
64. [Genetic factors for cerebral amyloid angiopathy].
Hamaguchi T; Yamada M
Brain Nerve; 2008 Nov; 60(11):1275-83. PubMed ID: 19069161
[TBL] [Abstract][Full Text] [Related]
65. Association of neprilysin polymorphism with cerebral amyloid angiopathy.
Yamada M; Sodeyama N; Itoh Y; Takahashi A; Otomo E; Matsushita M; Mizusawa H
J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):749-51. PubMed ID: 12754344
[TBL] [Abstract][Full Text] [Related]
66. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.
Thal DR; Griffin WS; de Vos RA; Ghebremedhin E
Acta Neuropathol; 2008 Jun; 115(6):599-609. PubMed ID: 18369648
[TBL] [Abstract][Full Text] [Related]
67. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA; Stewart J; Ironside JW; Mann DM; Love S; Graham DI; Dewar D
J Neuropathol Exp Neurol; 1999 Jul; 58(7):711-8. PubMed ID: 10411341
[TBL] [Abstract][Full Text] [Related]
68. Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease.
Han HJ; Kwon JC; Kim JE; Kim SG; Park JM; Park KW; Park KC; Park KH; Moon SY; Seo SW; Choi SH; Cho SJ
Eur Neurol; 2015; 73(1-2):23-8. PubMed ID: 25376930
[TBL] [Abstract][Full Text] [Related]
69. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
[TBL] [Abstract][Full Text] [Related]
70. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
71. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy.
Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
Ann Neurol; 1998 Jul; 44(1):129-31. PubMed ID: 9667601
[TBL] [Abstract][Full Text] [Related]
72. APOE and cerebral amyloid angiopathy in the elderly.
Love S; Nicoll JA; Hughes A; Wilcock GK
Neuroreport; 2003 Aug; 14(11):1535-6. PubMed ID: 12960780
[TBL] [Abstract][Full Text] [Related]
73. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
[TBL] [Abstract][Full Text] [Related]
74. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A
J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848
[TBL] [Abstract][Full Text] [Related]
75. BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.
Bizzarro A; Guglielmi V; Lomastro R; Valenza A; Lauria A; Marra C; Silveri MC; Tiziano FD; Brahe C; Masullo C
J Neural Transm (Vienna); 2010 Mar; 117(3):377-83. PubMed ID: 20058037
[TBL] [Abstract][Full Text] [Related]
76. Cerebral amyloid angiopathy and gene polymorphisms.
Yamada M
J Neurol Sci; 2004 Nov; 226(1-2):41-4. PubMed ID: 15537517
[TBL] [Abstract][Full Text] [Related]
77. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy.
Greenberg SM; Briggs ME; Hyman BT; Kokoris GJ; Takis C; Kanter DS; Kase CS; Pessin MS
Stroke; 1996 Aug; 27(8):1333-7. PubMed ID: 8711797
[TBL] [Abstract][Full Text] [Related]
78. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
79. Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors.
Itoh Y; Yamada M
J Med Dent Sci; 1997 Mar; 44(1):11-9. PubMed ID: 9385038
[TBL] [Abstract][Full Text] [Related]
80. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
